Ubs Group Ag Dynavax Technologies Corp Transaction History

Ubs Group Ag

  • $611 Billion
  • Q3 2025

A detailed history of Ubs Group Ag transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Ubs Group Ag holds 457,132 shares of DVAX stock, worth $5.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
457,132
Previous 405,868 12.63%
Holding current value
$5.06 Million
Previous $4.03 Million 12.74%
% of portfolio
0.0%
Previous 0.0%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$9.36 - $11.36 $479,831 - $582,359
51,264 Added 12.63%
457,132 $4.54 Million
Q2 2025

Aug 14, 2025
SELL
$9.4 - $12.87 $1.28 Million - $1.75 Million
-136,230 Reduced 25.13%
405,868 $4.03 Million
Q1 2025

May 13, 2025
BUY
$12.39 - $14.4 $3.61 Million - $4.19 Million
291,239 Added 116.1%
542,098 $7.03 Million
Q4 2024

Feb 14, 2025
BUY
$10.28 - $13.66 $76,956 - $102,258
7,486 Added 3.08%
250,859 $3.2 Million
Q3 2024

Nov 14, 2024
BUY
$10.05 - $11.61 $483,445 - $558,487
48,104 Added 24.63%
243,373 $2.71 Million
Q2 2024

Aug 13, 2024
SELL
$10.73 - $12.58 $2.66 Million - $3.11 Million
-247,557 Reduced 55.9%
195,269 $2.19 Million
Q1 2024

May 13, 2024
SELL
$11.7 - $14.98 $2.4 Million - $3.07 Million
-205,085 Reduced 31.65%
442,826 $5.5 Million
Q4 2023

Feb 09, 2024
BUY
$13.09 - $14.98 $6.87 Million - $7.86 Million
525,012 Added 427.19%
647,911 $9.06 Million
Q3 2023

Nov 09, 2023
SELL
$12.64 - $14.99 $2.3 Million - $2.73 Million
-181,862 Reduced 59.67%
122,899 $1.82 Million
Q2 2023

Aug 11, 2023
BUY
$9.85 - $13.17 $802,233 - $1.07 Million
81,445 Added 36.47%
304,761 $3.94 Million
Q1 2023

May 12, 2023
SELL
$9.44 - $11.88 $1.95 Million - $2.46 Million
-207,009 Reduced 48.11%
223,316 $2.19 Million
Q4 2022

Feb 08, 2023
BUY
$10.27 - $13.29 $3.19 Million - $4.13 Million
311,084 Added 260.89%
430,325 $4.58 Million
Q3 2022

Nov 10, 2022
BUY
$9.93 - $17.44 $120,073 - $210,884
12,092 Added 11.29%
119,241 $1.25 Million
Q2 2022

Aug 10, 2022
SELL
$7.45 - $12.83 $1.38 Million - $2.38 Million
-185,866 Reduced 63.43%
107,149 $1.35 Million
Q1 2022

May 16, 2022
BUY
$9.75 - $14.44 $2.56 Million - $3.79 Million
262,650 Added 864.98%
293,015 $3.18 Million
Q4 2021

Feb 14, 2022
BUY
$13.17 - $20.94 $69,959 - $111,233
5,312 Added 21.2%
30,365 $427,000
Q3 2021

Nov 15, 2021
SELL
$9.16 - $19.83 $217,476 - $470,803
-23,742 Reduced 48.66%
25,053 $481,000
Q2 2021

Aug 13, 2021
SELL
$7.25 - $10.99 $1.02 Million - $1.54 Million
-140,223 Reduced 74.18%
48,795 $481,000
Q1 2021

May 12, 2021
BUY
$4.57 - $11.18 $764,839 - $1.87 Million
167,361 Added 772.78%
189,018 $1.86 Million
Q4 2020

Feb 11, 2021
SELL
$3.73 - $5.6 $9,526 - $14,302
-2,554 Reduced 10.55%
21,657 $96,000
Q3 2020

Nov 12, 2020
BUY
$4.32 - $11.7 $63,188 - $171,135
14,627 Added 152.62%
24,211 $105,000
Q2 2020

Jul 31, 2020
SELL
$2.94 - $9.1 $91,633 - $283,628
-31,168 Reduced 76.48%
9,584 $85,000
Q1 2020

May 01, 2020
SELL
$2.27 - $6.2 $87,646 - $239,388
-38,611 Reduced 48.65%
40,752 $144,000
Q4 2019

Feb 14, 2020
BUY
$3.46 - $6.93 $37,143 - $74,393
10,735 Added 15.64%
79,363 $454,000
Q3 2019

Nov 14, 2019
BUY
$2.69 - $4.85 $129,792 - $234,012
48,250 Added 236.77%
68,628 $245,000
Q2 2019

Aug 14, 2019
SELL
$3.65 - $7.89 $95,659 - $206,781
-26,208 Reduced 56.26%
20,378 $82,000
Q1 2019

May 14, 2019
SELL
$7.08 - $12.09 $270,321 - $461,608
-38,181 Reduced 45.04%
46,586 $341,000
Q4 2018

Feb 14, 2019
BUY
$8.14 - $13.28 $198,835 - $324,390
24,427 Added 40.48%
84,767 $776,000
Q3 2018

Nov 14, 2018
BUY
$11.85 - $16.0 $566,821 - $765,328
47,833 Added 382.45%
60,340 $748,000
Q2 2018

Aug 14, 2018
SELL
$15.15 - $20.75 $3.67 Million - $5.03 Million
-242,180 Reduced 95.09%
12,507 $191,000
Q1 2018

May 15, 2018
BUY
$14.65 - $19.9 $2.38 Million - $3.23 Million
162,360 Added 175.85%
254,687 $5.06 Million
Q4 2017

Feb 14, 2018
SELL
$17.3 - $24.08 $312,818 - $435,414
-18,082 Reduced 16.38%
92,327 $1.73 Million
Q3 2017

Nov 14, 2017
BUY
$15.2 - $21.5 $1.11 Million - $1.57 Million
73,029 Added 195.37%
110,409 $2.37 Million
Q2 2017

Aug 14, 2017
BUY
N/A
34,088 Added 1035.48%
37,380 $361,000
Q1 2017

Nov 14, 2017
BUY
N/A
3,292
3,292 $20,000

Others Institutions Holding DVAX

# of Institutions
303
Shares Held
120M
Call Options Held
293K
Put Options Held
311K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.4B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email